{"organizations": [], "uuid": "24d5659e859d090a5f795abe3def97697f023629", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180108.html", "section_title": "Archive News &amp; Video for Monday, 08 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-athenex-announces-chinese-fda-allo/brief-athenex-announces-chinese-fda-allowance-of-investigational-new-drug-application-of-oraxol-to-begin-clinical-trials-idUSASB0C02Z", "country": "US", "domain_rank": 408, "title": "BRIEF-Athenex Announces Chinese FDA Allowance Of Investigational New Drug Application Of Oraxol To Begin Clinical Trials", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-01-08T21:16:00.000+02:00", "replies_count": 0, "uuid": "24d5659e859d090a5f795abe3def97697f023629"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-athenex-announces-chinese-fda-allo/brief-athenex-announces-chinese-fda-allowance-of-investigational-new-drug-application-of-oraxol-to-begin-clinical-trials-idUSASB0C02Z", "ord_in_thread": 0, "title": "BRIEF-Athenex Announces Chinese FDA Allowance Of Investigational New Drug Application Of Oraxol To Begin Clinical Trials", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "athenex inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 8 (Reuters) - Athenex Inc:\n* ATHENEX ANNOUNCES CHINESE FDA ALLOWANCE OF INVESTIGATIONAL NEW DRUG APPLICATION OF ORAXOL TO BEGIN CLINICAL TRIALS\n* ATHENEX INC - ACCEPTANCE OF ORAXOL IND BY CHINESE FDA ALLOWS ATHENEX TO COMMENCE A CLINICAL TRIAL PROGRAM FOR ORAXOL IN CHINA IN 2018 Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-08T21:16:00.000+02:00", "crawled": "2018-01-09T17:20:56.000+02:00", "highlightTitle": ""}